Company Overview and News

 
Nikkei falls on Syria tensions, retail sector driven by earnings

2018-04-12 thehindubusinessline
The Nikkei dropped 0.2 per cent to 21,655.22 in early morning trade. File Photo - Reuters
Upvote Downvote

 
ANA Holdings Forms Charter Co., Signs Deal With HondaJet

2018-03-28 aviationweek
ANA Holdings, Japan’s largest airline, will use HondaJet business jets for charter and feeder flights to connect passengers to its network at major travel hubs in North America and Europe, the two companies ...
Upvote Downvote

 
ANA Confirms Merger Of LCCs Peach, Vanilla Air

2018-03-22 aviationweek
All Nippon Airways (ANA) has decided to merge its LCC subsidiaries, Peach and Vanilla Air, after boosting its shareholding in Peach. The process of fully integrating the two LCCs will begin in the second half of ANA’s 2018 fiscal year (FY), which begins April 1. Parent company ANA Holdings aims to complete the merger by the end of FY2019. The company was previously reported to be considering such a move.
Upvote Downvote

 
Low-cost carriers Peach and Vanilla to merge in 2019: ANA

2018-03-22 japantimes.co.jp
Vanilla Air and Peach Aviation, two low-cost carriers owned by ANA Holdings, announced on Thursday plans to merge by the end of fiscal 2019.
Upvote Downvote

 
Tokyo stocks rebound from three-day losing streak thanks to buying on dips

2018-03-22 japantimes.co.jp
Stocks staged a rally Thursday, thanks to a wave of buying on dips after three straight days of losses.
Upvote Downvote

 
AirAsia in talks to set up Myanmar airline

2018-03-19 themalaymailonline
Tony Fernandes told Reuters that AirAsia Bhd is in talks with a potential partner to open an airline serving Myanmar. — Reuters file picHONG KONG, March 19 — Tony Fernandes’ AirAsia Bhd is in talks with a potential partner to open an airline serving Myanmar, in a move that would help the low-cost carrier cover up to 95 per cent of the Southeast Asian travel market.
Upvote Downvote

 
Nikkei falls to 4-month low as strong yen bites

2018-02-13 reuters
TOKYO, Feb 13 (Reuters) - Japan’s Nikkei share average gave up early gains and closed at at four-month low on Tuesday in choppy trade as investors turned risk averse again as the yen rose rising against the dollar.
Upvote Downvote

 
Nikkei rebounds after sharp weekly drop as US shares recover

2018-02-13 thehindubusinessline
Japan's Nikkei share average rebounded on Tuesday morning after suffering a sharp drop last week, as investors played catch-up after US shares rose on Monday, when markets were closed for a national holiday in Japan.
Upvote Downvote

 
Nikkei rebounds after sharp weekly drop as U.S. shares recover

2018-02-13 reuters
TOKYO, Feb 13 (Reuters) - Japan’s Nikkei share average rebounded on Tuesday morning after suffering a sharp drop last week, as investors played catch-up after U.S. shares rose on Monday, when markets were closed for a national holiday in Japan.
Upvote Downvote

 
ANA Considers Aircraft Options For Longer LCC Flights

2018-02-07 aviationweek
The All Nippon Airways (ANA) Group intends to use its existing LCCs Peach and Vanilla Air to launch its planned medium-haul low-cost operation, with aircraft types still to be decided. ANA Holdings recently announced its strategy to offer medium-haul LCC flights beginning about 2020. An ANA spokeswoman confirmed this market will be served by Vanilla and Peach, which now mainly fly short-haul domestic and international routes.
Upvote Downvote

 
Boeing signs nearly $1 billion of services deals, eyes $50 billion target

2018-02-06 moneycontrol
Boeing's services unit announced on Tuesday deals worth nearly $1 billion as part of its effort to more than triple the division's annual revenue to $50 billion in as little as five years.
Upvote Downvote

 
Boeing signs nearly US$1b of services deals, eyes US$50b target

2018-02-06 themalaymailonline
The first Boeing 737 MAX 7 is unveiled in Renton, Washington, US, February 5, 2018. — Reuters picSINGAPORE, Feb 6 — Boeing’s services unit announced today deals worth nearly US$1 billion as part of its effort to more than triple the division’s annual revenue to US$50 billion in as little as five years.
Upvote Downvote

 
Boeing signs nearly $1 billion of services deals, eyes $50 billion target

2018-02-06 in.reuters
SINGAPORE (Reuters) - Boeing’s services unit announced on Tuesday deals worth nearly $1 billion as part of its effort to more than triple the division’s annual revenue to $50 billion in as little as five years.
Upvote Downvote

 
AIRSHOW-Boeing signs nearly $1 bln of services deals, eyes $50 bln target

2018-02-06 reuters
SINGAPORE (Reuters) - Boeing’s services unit announced on Tuesday deals worth nearly $1 billion as part of its effort to more than triple the division’s annual revenue to $50 billion in as little as five years.
Upvote Downvote

 
Most markets in Asia decline following rise in US bond yields

2018-02-02 moneycontrol
Asian shares came under pressure early on Friday after Wall Street closed mixed and yields on US government debt rose in the last session.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 032350100